Originally, I wanted to do a detailed science popularization after attending, record my knowledge and talk about my experience as a clinical trial volunteer. Later. . . Too lazy to do it. hahahaha
I will attend again when I have the chance. Clinical trials are not as terrible as many people think. It is a good thing to publicize this kind of thing to many people.
Moreover, the income is still considerable. 4000 yuan is a small project. I don't think I need to be hospitalized. It only needs a few simple next steps. If it is a project that needs hospitalization, it is usually seven or eight thousand or tens of thousands.
Many hospitals in Shandong recruited COVID-19 patients for drug testing.
According to the evening news of Zibo First Hospital's micro-signal 65438+ 10/,Zibo First Hospital issued "Recruiting novel coronavirus Patients", saying that the Department of Respiratory and Critical Care Medicine of our hospital is carrying out "a randomized, double-blind, placebo-controlled clinical study to evaluate the safety and effectiveness of GS22 1 in the treatment of mild or ordinary novel coronavirus patients", with the scheme number of GS2266. This study is currently recruiting patients with mild or ordinary novel coronavirus, and it is planned to be carried out in about 20 clinical research centers across the country. Part B is expected to recruit a total of 365,438+02 patients.
This experiment is divided into two treatment groups. After screening, eligible subjects will be randomly treated with GS22 1 or placebo at a ratio of 3: 1 for 5 days, and each subject will take the study drug (GS22 1 or placebo) and warm water, and chewing is not allowed. Oral administration of 375mg once a day on the first day, followed by oral maintenance of 125mg once a day for 5 days. Follow-up was conducted until it was confirmed that the nucleic acid turned negative and all clinical symptoms disappeared or on the fourth day of the study.